Bioactivity of a Novel Polycaprolactone-Hydroxyapatite Scaffold Used as a Carrier of Low Dose BMP-2: An In Vitro Study

Scaffolds of polycaprolactone-30% hydroxyapatite (PCL-30% HA) were fabricated using melt stretching and multilayer deposition (MSMD), and the in vitro response of osteoblasts to the scaffolds was assessed. In group A, the scaffolds were immersed in 10 µg/mL bone morphogenetic protein-2 (BMP-2) solut...

Descripción completa

Detalles Bibliográficos
Autores principales: Rittipakorn, Pawornwan, Thuaksuban, Nuttawut, Mai-ngam, Katanchalee, Charoenla, Satrawut, Noppakunmongkolchai, Warobon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867198/
https://www.ncbi.nlm.nih.gov/pubmed/33535638
http://dx.doi.org/10.3390/polym13030466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867198/
https://www.ncbi.nlm.nih.gov/pubmed/33535638
http://dx.doi.org/10.3390/polym13030466

Ejemplares similares